Home
>
US Stocks
>
180 Life Sciences Corp
180 Life Sciences Corp
ATNF

180 Life Sciences Corp (ATNF)

$5.393.85%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.46
Today Low/High
5.34 / 5.46
52 Week Low/High
$1.9 / $13.05
Market Cap
$214.15M

Company Details

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world's biggest drivers of disease - inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company's primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.
Organisation
180 Life Sciences Corp
Employees
2
Industry
Finance

Discover more

Frequently Asked Questions

What is 180 Life Sciences Corp (ATNF) share price today?

Can Indians buy 180 Life Sciences Corp (ATNF) shares?

How can I buy 180 Life Sciences Corp (ATNF) shares from India?

Can Fractional shares of 180 Life Sciences Corp (ATNF) be purchased?

What are the documents required to start investing in 180 Life Sciences Corp (ATNF) stocks?

We are a SEBI registered investement advisor